skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Zach McLellan and Jack Allen are joined by guest analyst Maria Berezina. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting. Topics covered include:

  • Challenges in developing PD-1 combinations: LAG525, ECHO-301 trials (NVS IMMP INCY) - 0:50
  • When PD-1 blockade is inferior to SOC: Keytruda in MM (KEYNOTE-183/185) & Tecentriq+chemo in 1L NSCLC (IMpower131) (MRK RHHBY PFE BMY) - 17:00
  • Failure of taselisib in the SANDPIPER trial (RHHBY NVS PFE AZN) - 32:53

To learn more about Datamonitor Healthcare and our offerings, visit Datamonitor Healthcare

Listen to podcast below:





電話:+81 (0)3 6273 4260